8 completed, 2 unknown, 2 withdrawn. 5 Not applicable, 4 Phase 3, 2 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Unknown 2, Withdrawn 2, Completed 1 |
| Phase 3 | 4 | Completed 4 |
| Phase 1 | 2 | Completed 2 |
| Phase 4 | 1 | Completed 1 |
Follow diclofenac hydroxyethylpyrrolidine: new trials by email Literature Review of diclofenac hydroxyethylpyrrolidine trials Research Report on diclofenac hydroxyethylpyrrolidine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non-contrast Magnetic Resonance Angiography in Deep Inferior Epigastric Perforator Flap Breast Reconstruction Planning Non-contrast MRA in preoperative perforator vessels mapping for deep inferior epigastric perforator (DIEP) flap breast reconstruction planning., CTA with iodine contrast in preoperative perforator vessels mapping for deep inferior epigastric perforator (DIEP) flap breast reconstruction planning. - Breast Cancer, Postsurgical Acquired Absence of Organ | Not applicable | Unknown | I.M. Sechenov First Moscow State Medical University | 135 | 2023-05-06 | 2023-09-29 |
| Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury Licart™ (diclofenac epolamine) topical system - Soft Tissue Injuries | Phase 3 | Completed | IBSA Institut Biochimique SA | 151 | 2021-10-31 | 2026-09-30 |
| Clinical Trial With Diclofenac Sodium Medicated Plaster in Patients With Impact Injuries of the Limbs Diclofenac Sodium 140 mg medicated plaster, Diclofenac epolamine (DIEP) 180mg medicated plaster, Flector, Placebo - Trauma Injury, Inflammation | Phase 3 | Completed | Fidia Farmaceutici s.p.a. | 214 | 2018-05-25 | 2023-10-02 |
| Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a Day Diclofenac Sodium 140mg Medicated Plaster, Flector® topical plaster containing 180 mg of diclofenac hydroxyethylpyrrolidine equivalent to 140 mg of sodium diclofenac - Bioequivalence Study | Phase 1 | Completed | Fidia Farmaceutici s.p.a. | 52 | 2017-11-28 | 2020-10-14 |
| Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain Diclofenac epolamine, Placebo - Ankle Sprain | Phase 3 | Completed | Actavis Inc. | 658 | 2014-05-01 | 2020-06-24 |
| Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries Diclofenac hydroxyethylpyrrolidine - Athletic Injuries | Phase 4 | Completed | IBSA Institut Biochimique SA | 104 | 2014-05-01 | 2018-05-11 |
| Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial in Post ERCP Pancreatitis ERCP, Diclofenac hydroxyethylpyrrolidine, Normal Saline - Post-ERCP Acute Pancreatitis. | Phase 1 | Completed | Specialized Arab Hospital | 182 | 2012-06-01 | 2013-09-20 |
| Efficacy of PENNSAID® for Pain Management in the Emergency Department PENNSAID, Diclofenac hydroxyethylpyrrolidine - Pain, Ankle Sprain | Not applicable | Withdrawn | University of Utah | 2011-12-01 | 2016-12-21 | |
| Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients Diclofenac hydroxyethylpyrrolidine, orphenadrine, Tramadol - Pain Relief | Not applicable | Withdrawn | Western Galilee Hospital-Nahariya | 2010-12-31 | 2020-05-27 | |
| A Bilateral Interconnected DIEP Flap Based on One Vessel Pedicle for Breast Reconstruction DIEP, Interconnected DIEP - Mammaplasty | Not applicable | Completed | Chinese Academy of Sciences | 2007-01-01 | 2009-06-24 | |
| Management of the Sprained Ankle by Help of NSAID-Plaster flector - The Sprained Ankle | Not applicable | Unknown | Kolding Sygehus | 200 | 2006-02-01 | 2006-03-13 |
| Diabetes Health Enhancement Program to Improve Health of People With Diabetes DHEP - Diabetes | Phase 3 | Completed | Robert Wood Johnson Foundation | 146 | 2001-07-01 | 2006-02-14 |
Pain (3) · Ankle Injuries (2) · Accidental Injuries (1) · Agnosia (1) · Athletic Injuries (1) · Breast Neoplasms (1) · Diabetes Mellitus (1) · Inflammation (1) · Pancreatitis (1) · Soft Tissue Injuries (1)
Fidia Farmaceutici s.p.a. (2) · IBSA Institut Biochimique SA (2) · Actavis Inc. (1) · Chinese Academy of Sciences (1) · I.M. Sechenov First Moscow State Medical University (1) · Kolding Sygehus (1) · Robert Wood Johnson Foundation (1) · Specialized Arab Hospital (1) · University of Utah (1) · Western Galilee Hospital-Nahariya (1)
United States (5) · Italy (2) · China (1) · Denmark (1) · Germany (1) · Hungary (1) · Palestinian Territories (1) · Russia (1)
Nicola Giordan (2) · Clarence Jones, Ph.D. (1) · Dmitry V. Melnikov, MD, PhD (1) · Gayle E Reiber, PhD (1) · Giuseppe Mautone, MD (1) · Henry Lau, PhD (1) · Jie Luan, MD (1) · Nimrod Rahamimov, M.D. (1) · Richard Chapman, PhD (1) · Victor A. Gombolevskiy, MD, PhD (1) · Virgil Davis, MD (1) · Yasser Abu-Safieh, MD, AGAF (1)